An incident case-referent study on plasma enterolactone and breast cancer risk.
about
Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general populationBioavailability challenges associated with development of anti-cancer phenolics.Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study.Measuring exposure to the polyphenol metabolome in observational epidemiologic studies: current tools and applications and their limits.Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol.Can rye intake decrease risk of human breast cancer?Lignans and human health.Rye, lignans and human health.Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor statusCirculating enterolactone and risk of breast cancer: a prospective study in New YorkBreast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study.Plasma enterolactone and breast cancer risk in the Nurses' Health Study IILignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies.Phytochemicals and cancer risk: a review of the epidemiological evidence.Changes in 2-hydroxyestrone and 16alpha-hydroxyestrone metabolism with flaxseed consumption: modification by COMT and CYP1B1 genotype.Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada).Effect of dietary flaxseed on serum levels of estrogens and androgens in postmenopausal women.Dietary consumption of phytochemicals and breast cancer risk in Mexican women.Polyphenol levels in human urine after intake of six different polyphenol-rich beverages.Plant foods and oestrogen receptor - and -defined breast cancer: observations from the Malmo Diet and Cancer cohortValidation of FFQ-based assessment of dietary lignans compared with serum enterolactone in Swedish women
P2860
Q33588118-DACCD47A-278B-49E9-B34F-A5636F2FDF82Q34057398-D1E73929-CF56-44BE-AF0E-2D1B98C43B57Q34060204-38303724-BB6F-4039-A922-86F485B43A51Q34087153-497470F7-9F55-42BF-80E5-22228C5B4D87Q34416493-F9D1CA50-09BE-4959-8798-36CE70F2D5D5Q34566886-DAC250FA-DFD8-40C8-A030-ADC9D7F0FF13Q34702636-DE2C95FF-6C9A-44AD-97E1-E9162E78638EQ35128398-1ACC1116-9CD4-4F51-8566-B34A4B485CDEQ36539431-494E8F5B-D194-4654-8251-E07DEF4C60FBQ36625914-16FD8294-B0AA-4644-AC84-A533B1ED3D0AQ36678705-548C5E9F-B7E7-49D6-97B2-2CB489DF4BD0Q37077392-4FFCFEF8-A765-45EA-981F-681BCEDA5B1FQ37222654-9E1363C1-B9C4-4201-A459-D94D1B87D751Q38033418-2B36B9C9-63D2-4066-84CF-298831FD4141Q41688138-1CF1648C-18EF-42E9-A8BD-787AD7C4900EQ43561419-16F6D8BA-1B12-4BEA-AA92-36A80E0C0317Q44294964-E1E5AC4E-C01E-421D-92D4-ED679954D753Q46367637-199F98D6-2174-4CDA-968D-4F19CA0DA2C7Q46468802-D21F4661-76E4-4879-AAE5-B09517ACEF7FQ46730137-D8B9777E-B13C-42DA-AC45-805F999C56C2Q57271610-12C5E142-7BB3-4BD2-84BC-77D88D1A1686Q58204472-5FDA083E-4853-4FE8-9BDE-E0A0D347FCE4
P2860
An incident case-referent study on plasma enterolactone and breast cancer risk.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
An incident case-referent study on plasma enterolactone and breast cancer risk.
@en
An incident case-referent study on plasma enterolactone and breast cancer risk.
@nl
type
label
An incident case-referent study on plasma enterolactone and breast cancer risk.
@en
An incident case-referent study on plasma enterolactone and breast cancer risk.
@nl
prefLabel
An incident case-referent study on plasma enterolactone and breast cancer risk.
@en
An incident case-referent study on plasma enterolactone and breast cancer risk.
@nl
P2093
P1476
An incident case-referent study on plasma enterolactone and breast cancer risk.
@en
P2093
Anna Winkvist
Herman Adlercreutz
Kerstin Hultén
Robert Johansson
P2888
P304
P356
10.1007/S00394-002-0373-3
P577
2002-08-01T00:00:00Z